Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II Journal Article

  

Authors:	O'connor, O.; Wright, J.; Moskowitz, C. H.; Muzzy, J.; Macgregor-Cortelli, B.; Hamlin, P.; Straus, D.; Trehu, E.; Schenkein, D. P.; Zelenetz, A. D.
Article Title:	Promising activity of the proteasome inhibitor bortezomib (VELCADE) in the treatment of indolent non-Hodgkin's lymphoma and mantle cell lymphoma: ASH poster session 517-II
Abstract:	Dr. O'Connor delivered the following material as a poster at the 2003 American Society of Hematology meeting highlighting results from his work with bortezomib in the treatment of non-Hodgkin's and mantle cell lymphoma. A full publication of his results will appear later this year. Abstract #2346 appears in Blood, Volume 102, issue 11, November 16, 2003. The American Society of Hematology Poster Session "Lymphoma: Treatment and Supportive Care" took place on Sunday, December 7, 2003.
Keywords:	bortezomib; proteasome; mantle cell lymphoma; boronic acids; protease inhibitors; proteasome endopeptidase complex; pyrazines; drug antagonism; nonhodgkin lymphoma; lymphoma, non-hodgkin; boronic acid derivative; proteinase inhibitor; pyrazine derivative; lymphoma, mantle-cell; humans; human; article
Journal Title:	Journal of the National Comprehensive Cancer Network
Volume:	2
Issue:	Suppl.4
ISSN:	1540-1405
Publisher:	Harborside Press
Date Published:	2004-11-01
Start Page:	S21
End Page:	22
Language:	English
PROVIDER:	scopus
PUBMED:	19791425
DOI/URL:	http://www.scopus.com/inward/record.url?eid=2-s2.0-70349895631&partnerID=40&md5=08a9d332320c488c9af94e5e313b9a56
Notes:	J Natl Compr Canc Netw -- Export Date: 16 June 2014 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/52830